SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Universal Health Services Inc – ‘10-K’ for 12/31/19 – ‘EX-31.2’

On:  Wednesday, 2/26/20, at 4:19pm ET   ·   For:  12/31/19   ·   Accession #:  1564590-20-6793   ·   File #:  1-10765

Previous ‘10-K’:  ‘10-K’ on 2/27/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/25/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/27/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/20  Universal Health Services Inc     10-K       12/31/19  113:28M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   3.07M 
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     32K 
 3: EX-10.3     Material Contract                                   HTML     33K 
 4: EX-21       Subsidiaries List                                   HTML    104K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
111: R1          Document and Entity Information                     HTML    107K  
47: R2          Consolidated Statements of Income                   HTML    103K 
34: R3          Consolidated Statements of Comprehensive Income     HTML     71K 
74: R4          Consolidated Balance Sheets                         HTML    179K 
112: R5          Consolidated Balance Sheets (Parenthetical)         HTML     49K  
48: R6          Consolidated Statements of Changes in Equity        HTML    116K 
35: R7          Consolidated Statements of Changes in Equity        HTML     45K 
                (Parenthetical)                                                  
78: R8          Consolidated Statements of Cash Flows               HTML    142K 
110: R9          Business and Summary of Significant Accounting      HTML    423K  
                Policies                                                         
76: R10         Acquisitions and Divestitures                       HTML     58K 
108: R11         Financial Instruments and Fair Value Measurement    HTML    218K  
49: R12         Long-Term Debt                                      HTML    125K 
32: R13         Common Stock                                        HTML    292K 
77: R14         Income Taxes                                        HTML    307K 
109: R15         Lease Commitments                                   HTML    188K  
50: R16         Commitments and Contingencies                       HTML    141K 
33: R17         Relationship with Universal Health Realty Income    HTML     71K 
                Trust and Other Related Party Transactions                       
75: R18         Revenue Recognition                                 HTML    328K 
113: R19         Pension Plan                                        HTML    282K  
55: R20         Segment Reporting                                   HTML    194K 
16: R21         Quarterly Results                                   HTML    201K 
79: R22         Schedule II-Valuation and Qualifying Accounts       HTML    107K 
89: R23         Business and Summary of Significant Accounting      HTML    490K 
                Policies (Policies)                                              
56: R24         Business and Summary of Significant Accounting      HTML    377K 
                Policies (Tables)                                                
17: R25         Acquisitions and Divestitures (Tables)              HTML     49K 
80: R26         Financial Instruments and Fair Value Measurement    HTML    208K 
                (Tables)                                                         
90: R27         Long-Term Debt (Tables)                             HTML    110K 
57: R28         Common Stock (Tables)                               HTML    295K 
15: R29         Income Taxes (Tables)                               HTML    299K 
37: R30         Lease Commitments (Tables)                          HTML    189K 
53: R31         Commitments and Contingencies (Tables)              HTML     97K 
107: R32         Relationship with Universal Health Realty Income    HTML     55K  
                Trust and Other Related Party Transactions                       
                (Tables)                                                         
73: R33         Revenue Recognition (Tables)                        HTML    322K 
36: R34         Pension Plan (Tables)                               HTML    293K 
52: R35         Segment Reporting (Tables)                          HTML    194K 
106: R36         Quarterly Results (Tables)                          HTML    184K  
72: R37         Business and Summary of Significant Accounting      HTML    253K 
                Policies - Additional Information (Detail)                       
38: R38         Uncompensated Care (Detail)                         HTML     40K 
51: R39         Estimated Cost of Providing Uncompensated Care      HTML     38K 
                (Detail)                                                         
19: R40         Summary of Cash, Cash Equivalents and Restricted    HTML     46K 
                Cash Reported In Consolidated Statements of Cash                 
                Flows (Detail)                                                   
60: R41         Summary of Changes in Carrying Amount of Goodwill   HTML     50K 
                (Detail)                                                         
96: R42         Summary of Net Intangible Assets (Detail)           HTML     43K 
87: R43         Summary of Net Intangible Assets (Parenthetical)    HTML     33K 
                (Detail)                                                         
18: R44         Amounts Recognized in AOCI (Detail)                 HTML     71K 
59: R45         Computation of Basic and Diluted Earnings Per       HTML     73K 
                Share (Detail)                                                   
95: R46         Acquisitions and Divestitures - Additional          HTML     63K 
                Information (Detail)                                             
86: R47         Aggregate Net Purchase Price Allocation to Assets   HTML     51K 
                and Liabilities based on Estimated Fair Values                   
                (Detail)                                                         
20: R48         Financial Instruments and Fair Value Measurement -  HTML     59K 
                Additional Information (Detail)                                  
58: R49         Summary of Effects of Interest Rate Swap            HTML     46K 
                Agreements and Foreign Currency Foreign Exchange                 
                Contracts on Result of Operations (Detail)                       
40: R50         Summary of Effects of Interest Rate Swap            HTML     40K 
                Agreements and Foreign Currency Foreign Exchange                 
                Contracts on Result of Operations (Parenthetical)                
                (Detail)                                                         
25: R51         Summary of Assets and Liabilities Recorded at Fair  HTML     66K 
                Value on Recurring Basis (Detail)                                
70: R52         Summary of Long-Term Debt (Detail)                  HTML     72K 
104: R53         Summary of Long-Term Debt (Parenthetical) (Detail)  HTML     55K  
41: R54         Long-Term Debt - Additional Information (Detail)    HTML    179K 
26: R55         Aggregate Scheduled Maturities of Debt Outstanding  HTML     60K 
                (Detail)                                                         
71: R56         Common Stock - Additional Information (Detail)      HTML    142K 
105: R57         Schedule of Information Related to Stock            HTML     95K  
                Repurchase Programs (Detail)                                     
42: R58         Schedule of Information Related to Stock            HTML     37K 
                Repurchase Programs (Parenthetical) (Detail)                     
24: R59         Assumptions Used in Black-Scholes Model to          HTML     45K 
                Determine Fair Value for Stock Option Awards                     
                Granted (Detail)                                                 
82: R60         Summary of Option Activities (Detail)               HTML     60K 
91: R61         Schedule of Information about Unvested Options      HTML     53K 
                (Detail)                                                         
61: R62         Schedule of Information about All Outstanding       HTML     54K 
                Options (Detail)                                                 
21: R63         Schedule of Weighted Average Remaining Contractual  HTML     52K 
                Life for Options Outstanding and Weighted Average                
                Exercise Price Per Share for Exercisable Options                 
                (Detail)                                                         
85: R64         Components of Income Tax Expense Benefit (Detail)   HTML     61K 
93: R65         Income Taxes - Additional Information (Detail)      HTML    139K 
63: R66         Reconciliation between Federal Statutory Rate and   HTML     57K 
                Effective Tax Rate (Detail)                                      
23: R67         Components of Deferred Taxes (Detail)               HTML     76K 
81: R68         Reconciliation of Unrecognized Tax Benefits         HTML     44K 
                (Detail)                                                         
94: R69         Lease Commitments - Additional Information          HTML     58K 
                (Detail)                                                         
103: R70         Components of Lease Expense (Detail)                HTML     47K  
67: R71         Supplemental Cash Flow Information Related to       HTML     47K 
                Leases (Detail)                                                  
31: R72         Supplemental Balance Sheet Information Related to   HTML     74K 
                Leases (Detail)                                                  
46: R73         Future Maturities of Lease Liabilities (Detail)     HTML     71K 
99: R74         Future Minimum Rental Payments under Lease          HTML     83K 
                Commitments (Detail)                                             
64: R75         Commitments and Contingencies - Additional          HTML    218K 
                Information (Detail)                                             
28: R76         Commitments and Contingencies - Schedule of         HTML     46K 
                Changes in General and Professional Liability and                
                Workers Compensation Reserves (Detail)                           
43: R77         Relationship with Universal Health Realty Income    HTML    163K 
                Trust and Other Related Party Transactions -                     
                Additional Information (Detail)                                  
98: R78         Remaining Renewal Options and Terms for Hospital    HTML     46K 
                Facilities Leased from Trust (Detail)                            
69: R79         Remaining Renewal Options and Terms for Hospital    HTML     55K 
                Facilities Leased from Trust (Parenthetical)                     
                (Detail)                                                         
102: R80         Schedule of Disaggregates Revenue by Major Source   HTML    133K  
                (Detail)                                                         
66: R81         Pension Plan - Additional Information (Detail)      HTML     48K 
30: R82         Schedule of Reconciliation of Defined Benefit       HTML     71K 
                Pension Plan (Detail)                                            
45: R83         Components of Net Periodic Pension Cost Benefit     HTML     47K 
                (Detail)                                                         
101: R84         Schedule of Measurement Dates (Detail)              HTML     38K  
65: R85         Schedule of Weighted Average Assumptions (Detail)   HTML     44K 
29: R86         Schedule of Market Values of Pension Plan Assets    HTML     58K 
                (Detail)                                                         
44: R87         Schedule of Estimated Future Benefit Payments       HTML     47K 
                (Detail)                                                         
97: R88         Schedule of Plan Assets Category (Detail)           HTML     41K 
68: R89         Schedule of Asset Allocation Policy and Ranges for  HTML     46K 
                Overall Risk and Return Objectives of Portfolio                  
                (Detail)                                                         
83: R90         Segment Reporting (Detail)                          HTML     78K 
92: R91         Segment Reporting (Parenthetical) (Detail)          HTML     61K 
62: R92         Quarterly Results (Detail)                          HTML     67K 
22: R93         Quarterly Results - Additional Information          HTML     54K 
                (Detail)                                                         
84: R94         Valuation and Qualifying Accounts (Detail)          HTML     45K 
27: XML         IDEA XML File -- Filing Summary                      XML    209K 
39: XML         XBRL Instance -- uhs-10k_20191231_htm                XML   7.61M 
100: EXCEL       IDEA Workbook of Financial Reports                  XLSX    165K  
11: EX-101.CAL  XBRL Calculations -- uhs-20191231_cal                XML    358K 
12: EX-101.DEF  XBRL Definitions -- uhs-20191231_def                 XML   1.26M 
13: EX-101.LAB  XBRL Labels -- uhs-20191231_lab                      XML   2.57M 
14: EX-101.PRE  XBRL Presentations -- uhs-20191231_pre               XML   1.92M 
10: EX-101.SCH  XBRL Schema -- uhs-20191231                          XSD    355K 
88: JSON        XBRL Instance as JSON Data -- MetaLinks              629±  1.00M 
54: ZIP         XBRL Zipped Folder -- 0001564590-20-006793-xbrl      Zip    589K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

 

Exhibit 31.2

CERTIFICATION—Chief Financial Officer

I, Steve Filton, certify that:

1. I have reviewed this annual report on Form 10-K of Universal Health Services, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 26, 2020

 

/S/    STEVE FILTON

Executive Vice President and Chief Financial Officer

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/26/208-K
For Period end:12/31/19
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/24  Universal Health Services Inc.    10-K       12/31/23  120:23M                                    Donnelley … Solutions/FA
 2/27/23  Universal Health Services Inc.    10-K       12/31/22  108:30M                                    Donnelley … Solutions/FA
 2/24/22  Universal Health Services Inc.    10-K       12/31/21  108:27M                                    ActiveDisclosure/FA
 2/25/21  Universal Health Services Inc.    10-K       12/31/20  113:28M                                    ActiveDisclosure/FA
Top
Filing Submission 0001564590-20-006793   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 5:45:02.1pm ET